IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
Site
RSS
Apple
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
IDEA Collider- with IDEA Pharma COO Jacqueline Barendregt and Exploristics Founder & CEO Aiden Flynn
Season 2 · Episode 16
Wednesday, May 8, 2024 • Duration 18:33
We are excited to tell you more about the IDEA Pharma and Exploristics partnership.
IDEA’s COO, Jacqui Barendregt, asked Exploristics Founder and CEO Aiden Flynn five key questions about the innovative service model and, most importantly, the value to the pharmaceutical industry this newly formed partnership will bring.
Embracing Innovation and Collaboration in the Pharma Industry with Dr. Nedim Pipic
Season 2 · Episode 15
Wednesday, June 14, 2023 • Duration 39:16
Welcome to another episode of Idea Collider with your host, Mike Rea.
In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference. Join us as we explore the unmet needs in these areas, the power of hybrid approaches and precision psychiatry, and the integration of digital therapeutics.
Discover how the industry is transforming lives through innovation while remaining patient-centric. With insights into measuring development quality, the advantages of being a private company, and the importance of collaboration, this episode will inspire you to embrace change and drive positive outcomes in the pharmaceutical landscape.
Tune in to Idea Collider today and be part of the movement toward a healthier, sustainable, and equitable future.
Chapter Summaries
[0:00:21] Introduction to today's guest, Dr. Nedim Pipic
[0:04:23] Discussion on Innovation and Growth Mindset
[0:06:44] Innovation and Patient Benefit in the Pharmaceutical Industry: A Discussion on the Importance of Return on Invention and Understanding Unmet Needs in Mental Health
[0:08:25] Innovating Mental Health: A Discussion on Precision Psychiatry and Unmet Patient Needs
[0:14:39] A Discussion on Precision Medicine and the Importance of Understanding Neurobiology in Addressing Symptoms
[0:16:39] Driving Innovation in Pharma: Importance of Early Research Collaborations and Agile Culture
[0:18:52] Discussion on Innovation and R&D in Pharmaceutical Industry
[0:20:22] Driving Innovation and Culture in a Private Pharmaceutical Company
[0:23:41] Insights on Innovation and Transformation
[0:25:46] The Importance of Seeking Inspiration Outside of the Pharma Industry: A Conversation on AI and Agile Transformation
[0:27:04] A Discussion on the Intersection of Medicine and Business in Pharmaceutical Innovation
[0:33:28] Discussion on the Future of the Pharma and Biotech Industry and the Importance of Innovation and Collaboration
[0:36:06] The Future of the Pharma Industry: Collaboration, Patient Empowerment, and Sustainability
Asymmetric Learning and Its Impact On Culture with John Waid
Season 2 · Episode 6
Wednesday, November 2, 2022 • Duration 47:40
Welcome to another amazing episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. In today’s episode, Mike is joined by John Waid. John is a thought leader, author, and CEO of a unique boutique global culture & leadership development firm. He talks about culture and the purpose of an organization.
Additionally, he talks about the importance of knowing your; purpose, mission, values, and principles of behavior and why most professionals who are promoted based on their skill sets fail when promoted to leadership positions. Moreover, he shares how to start building a successful workplace culture.
Tune in!
During this episode, you will learn about;
[00:22] Episode introduction
[00:36] Today’s focus; Asymmetric learning and its impact on culture
[00:55] Know our guest; John Waid
[03:01] What is culture?
[05:41] The purpose of an organization
[10:36] Examples of companies and their values
[14:46] Why he came up with the principle of three values
[16:34] The importance of respectful spirit value
[19:19] Why you should know your; purpose, mission, values, and principles of behavior
[22:16] Why most professionals who are promoted based on their skillsets fail when promoted to leadership positions
[26:27] Chick-fil-A’s values and culture
[32:31] Why one company outperforms the other
Creativity & Innovation In Corporate Venture With Rita McGrath
Season 2 · Episode 5
Wednesday, October 26, 2022 • Duration 59:49
Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by a consultant, best-selling author, and one of the world’s top experts on strategy and innovation, Rita McGrath.
In the episode, Rita talks to us about her transition from a political science career to innovation in the corporate venture, how to build an innovation program, challenges in implementation, and why you need multiple funding sources while championing an idea. Additionally, we delve into making that 10x shift in a company, discovery-driven planning, strategic inflection points & best books she would recommend.
Tune in for more innovation insights!
[02:01] About Rita McGrath
[05:10] Rita’s books
[11:55] Tips for building an innovation program
[16:10] Why do companies have one innovation process
[18:45] Reasons companies prefer false confidence instead of the uncertain approach
[27:40] How to get an organization to make a shift to a big place
[34:11] Rita’s thoughts on creativity
[37:25] Why you should have multiple sources of funding & approval
[37:54] Being future forward on failure & interrogating failure
[43:48] Problems related to assumptions in planning
[49:39] Discovery-driven planning
[51:01] Strategic inflection points
[55:05] Books Rita would recommend
[57:16] This or that question (Disruption or innovation)
[58:13] To connect with McGrath
Mentioned Books
Using AI In Drug Discovery With Andrew Hopkins
Season 2 · Episode 4
Wednesday, October 19, 2022 • Duration 50:34
Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Andrew Hopkins, the Founder & CEO of Exscientia, as he talks to us about the use of AI in drug discovery.
In the episode, we delve into Andrew’s journey of developing better drug discovery methods, applying data mining in drug discovery, and the value of data integration in the pharmaceutical industry. Additionally, he expounds on what AI drugs look like and future plans for Exscientia.
Tune in!
During this episode, you will learn about;
[01:12] Introducing Andrew Hopkins & his journey to his current role
[06:27] Applying data mining approach & machine learning
[12:10] What Andrew saw that others were not seeing
[19:06] The value of data integration
[22:02] The role of asking questions & finding answers in tech or data
[26:46] How Hopkins addresses being referred to as the AI discovery group
[33:08] Active learning approaches
[39:06] What an AI drug looks like & what it’s better at
[42:17] The future of AI drugs & Exscientia future plans in establishing clinics
[46:34] What do the next couple of years look like regarding solutions Andrew wished he had 5-10 years ago?
Follow, Rate, Review, Like, and Share!
The Misconceptions In The Pharma Industry With John L. Lamattina
Season 2 · Episode 3
Wednesday, October 12, 2022 • Duration 01:02:56
In this incredible episode, Mike Rea is joined by Dr. John L. LaMattina. John is the former Senior Vice President of Pfizer Inc and President of Pfizer Global Research & Development. Additionally, he is a senior partner at PureTech Health and an author. He talks about the misconception about Pfizer’s profiteering from the pandemic and the drug pricing in America.
John also discusses how Gilead’s Sovaldi drug for hepatitis C became overpriced in the US and the effects of insurance companies on the drug market. Moreover, he talks about the misinformation about insulin and its pricing, NIH’s role in drug discovery research, and the profitability of the pharma industry.
Tune in!
During this episode, you will learn about;
[00:22] Introduction to the show
[0:42] Know our guest; Dr. John L. LaMattina, and why he has authored his books
[04:58] Misconception about Pfizer’s profiteering from the pandemic
[08:13] Drug pricing in America
[12:35] Gilead’s Sovaldi drug for hepatitis C and how it became overpriced in the US more than in other countries
[19:57] The cost-effectiveness of PCSK9 in regulating (low-density lipoprotein) LDL cholesterol
[21:42] Effect the insurance companies have had on the drug market
[26:09] Value of the ‘me-too’ drugs
[30:01] The inefficiency of the flu vaccines
[33:03] The funding for early-stage mRNA vaccines
[34:23] The input of the FDA and CDC in the manufacture of mRNA vaccines
Asymmetric Learning in Cybersecurity & Intelligence with Gene Yoo
Season 2 · Episode 2
Wednesday, October 5, 2022 • Duration 47:23
Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. Today we are joined by Gene Yoo, the Chief Executive Officer at Resecurity, Inc. He talks about asymmetric learning in cybersecurity & Intelligence and what gives Resecurity an edge over other competitors in the market
Moreover, he shares about the signal validation process at Resecurity, how to understand the vulnerability of your business and what you need to combat cyber threats. In addition, Gene talks about the ‘what if’ component in their learning approach and the leadership style & culture at Resecurity.
Tune in!
During this episode, you will learn about;
[00:23] Introduction to the show
[01:23] What this series is about; Asymmetric learning
[04:41] Definition of insight in cybersecurity
[07:07] What is cyber threat intelligence about, and how should threat intelligence data be interpreted to deliver actionable insights?
[10:37] Security theater
[14:40] How Resecurity identifies a threat
[19:58] Understanding the vulnerability of your business and what you need to combat cyber threats
[22:52] Do they provide threat solutions or just threat evidence?
[24:22] The ‘what if’ component in their learning approach
[27:36] What gives Resecurity an edge over other cybersecurity & Intelligence companies in the market?
Where Do Good Ideas Come from? With Steven Johnson
Season 2 · Episode 1
Wednesday, September 28, 2022 • Duration 58:33
Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. In today’s episode, Mike interviews Steven Johnson, an author of 13 books, a TV host, and a podcaster. He talks about Innovation vs. Invention and explains where good ideas come from.
Additionally, Steven talks about the Individual and organizational hunch collection tools and shares how organizational culture impacts innovation. Moreover, he talks about his books The Ghost Map and Farsighted.
Tune in!
During this episode, you will learn about;
[01:05] Meet Steven Johnson and hear his backstory
[03:03] Innovation vs. Invention
[05:26] Where do good ideas ‘soul hunches’ come from?
[09:32] Reason why play and delight are linked to profound innovation
[12:52] Organizational culture and innovation
[17:12] How the daily schedule for his writing work looks like
[10:1414] Steven’s discovery process
[26:59] How Steven uses Twitter as a source of scientific discovery
[30:58] Individual and organizational hunch collection tools
[39:10]The Ghost Map and how it evolved from the format to a published book
Welcome Back to Series II of IDEA Collider
Season 2
Wednesday, September 28, 2022 • Duration 00:47
Sick Money: The Truth About The Global Pharmaceutical Industry With Billy Kenber
Season 1
Wednesday, June 22, 2022 • Duration 58:06
Welcome to another fantastic episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Billy Kenber, an investigative journalist at “The Times.” He talks about his journey to writing his book ‘Sick Money’ and the content in the book.
Additionally, he talks about the pharmaceutical industry’s social contract with patients and how its distortion has led to pharmaceutical greed. Moreover, he shares how the culture within the pharmaceutical industry has changed, why drug companies overprice the drugs, and what can be done to regulate drug pricing.
Tune in!
During this episode, you will learn about;
[00:22] Episode introduction
[01:08] Meet our guest; Billy Kenber
[01:22] His journey to writing his book ‘Sick Money’
[03:28] What the book is about
[06:11] How Concordia Pharmaceuticals & Valeant Pharmaceuticals companies
grew quickly and gained a short-term monopoly, thus hiking the drug prices
[10:40] What’s the geographical scope of the pharmaceutical fraud
[12:47] Pharmaceutical industry’s social contract with patients and how its distortion has led to pharmaceutical greed
[15:20] The first AIDS drug; AZT
[18:30] A background of AZT drug high pricing and how it led to other
pharmaceutical companies raising their prices
[22:47] How Pharmacy Benefit Managers (PBMs) raise drug prices for patients
[25:39] The ’Dirty Pharma’ chapter in his book
[37:16] Can culture be built virtually?
[40:25] How to start building a successful workplace culture
[42:53] Disruption vs Innovation
[45:09] How to connect with John Waid
Love the show? Follow, Rate, Review, Like, and Share!
Discover shows related to IDEA Collider: Innovation & Asymmetric Learning in Pharma, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
